Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.8M Buy
955,198
+942,741
+7,568% +$6.25M ﹤0.01% 2277
2026
Q1
$64.5K Sell
12,457
-91,682
-88% -$574K ﹤0.01% 4320
2025
Q4
$761K Sell
104,139
-922,944
-90% -$8.94M ﹤0.01% 3705
2025
Q3
$10.2M Buy
1,027,083
+1,015,073
+8,452% +$11.2M 0.01% 1668
2025
Q2
$109K Buy
+12,010
New +$78.3K ﹤0.01% 4121
2024
Q1
Sell
-105,088
Closed -$912K 4429
2023
Q4
$1.15M Buy
+105,088
New +$1.03M ﹤0.01% 3047
2023
Q2
Sell
-652,795
Closed -$7.59M 4315
2023
Q1
$8.52M Sell
652,795
-42,949
-6% -$353K 0.01% 1491
2022
Q4
$7.57M Buy
695,744
+636,739
+1,079% +$7.83M 0.01% 1695
2022
Q3
$947K Buy
59,005
+21,866
+59% +$323K ﹤0.01% 3633
2022
Q2
$290K Sell
37,139
-98,963
-73% -$931K ﹤0.01% 4373
2022
Q1
$1.7M Buy
+136,102
New +$1.91M ﹤0.01% 3464
2021
Q4
Sell
-93,878
Closed -$1.55M 5482
2021
Q3
$1.55M Buy
+93,878
New +$1.41M ﹤0.01% 3245
2021
Q2
Sell
-103,877
Closed -$1.21M 4809
2021
Q1
$1.21M Buy
+103,877
New +$1.36M ﹤0.01% 2970

Other funds holding ENVX

David Shaw's ENVX Position: Q2 2026 in Review

David Shaw increased its Enovix (ENVX) stake by 7,568% in Q2 2026, buying an estimated $6.25M and bringing the position to 955,198 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

David Shaw first reported a position in ENVX in Q1 2021 and has held it in 13 quarters since. The position peaked at $10.2M in Q3 2025. 297 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • David Shaw held 955,198 shares of Enovix worth $5.8M as of Q2 2026.
  • David Shaw bought 942,741 Enovix shares in Q2 2026, an estimated $6.25M.
  • Enovix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2277 holding.
  • David Shaw first reported a position in Enovix in Q1 2021 and has held it in 13 quarters since.
  • David Shaw's Enovix position peaked at $10.2M in Q3 2025.
  • 297 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.